Rajkumar SV. Multiple myeloma: 2024 update on diagnosis, risk-stratification, and management. Am J Hematol. 2024;99(9):1802–24.
Article PubMed PubMed Central Google Scholar
Malard F, et al. Multiple myeloma. Nat Rev Dis Primers. 2024;10(1):45.
Lin CH, et al. Current novel targeted therapeutic strategies in multiple myeloma. Int J Mol Sci. 2024. https://doi.org/10.3390/ijms25116192.
Article PubMed PubMed Central Google Scholar
Engelhardt M, et al. Functional cure and long-term survival in multiple myeloma: how to challenge the previously impossible. Haematologica. 2024;109(8):2420–35.
PubMed PubMed Central CAS Google Scholar
Sung H, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49.
Siegel RL, et al. Cancer statistics, 2025. CA Cancer J Clin. 2025;75(1):10–45.
PubMed PubMed Central Google Scholar
Dimopoulos MA, et al. Multiple myeloma: EHA-ESMO clinical practice guidelines for Diagnosis, treatment and Follow-up. Hemasphere. 2021;5(2):e528.
PubMed PubMed Central CAS Google Scholar
Morè S, et al. The challenging approach to multiple myeloma: from disease diagnosis and monitoring to complications management. Cancers (Basel). 2024. https://doi.org/10.3390/cancers16122263.
Long B, et al. An emergency medicine review: multiple myeloma and its complications. Am J Emerg Med. 2025;88:172–9.
Kumar SK, et al. Multiple myeloma. Nat Rev Dis Primers. 2017;3:17046.
Lu Q, et al. Multiple myeloma: signaling pathways and targeted therapy. Mol Biomed. 2024;5(1):25.
Article PubMed PubMed Central Google Scholar
Ebraheem MS, et al. Quadruplet regimens for patients with newly diagnosed multiple myeloma: a systematic review and meta-analysis. Blood Adv. 2024;8(23):5993–6002.
Article PubMed PubMed Central CAS Google Scholar
Zhang H, et al. Time trends in multiple myeloma incidence and mortality across the BRICS from 1992 to 2021 and projection to 2046. BMC Public Health. 2025;25(1):1765.
Article PubMed PubMed Central Google Scholar
Mousavi SE, et al. Epidemiology, socioeconomic correlates, and trend projections of multiple myeloma in Asia over 2020–2040. Heliyon. 2025;11(9):e43325.
Sun C, et al. Identification of a novel lactylation-related gene signature predicts the prognosis of multiple myeloma and experiment verification. Sci Rep. 2024;14(1):15142.
Article PubMed PubMed Central CAS Google Scholar
Frede J et al. The endogenous T cell landscape is reshaped by CAR-T cell therapy and predicts treatment response in multiple myeloma. Leukemia. 2025.
Agafonova A, et al. Breaking barriers: the role of the bone marrow microenvironment in multiple myeloma progression. Int J Mol Sci. 2025. https://doi.org/10.3390/ijms26157301.
Article PubMed PubMed Central Google Scholar
Dingli S, et al. The ratio of brain to liver glucose activity and disease activity in multiple myeloma. Blood Cancer J. 2025;15(1):90.
Article PubMed PubMed Central Google Scholar
Zhou X, et al. Targeting myeloma metabolism: how abnormal metabolism contributes to multiple myeloma progression and resistance to proteasome inhibitors. Neoplasia. 2024;50:100974.
Article PubMed PubMed Central CAS Google Scholar
Barbato A, et al. Mitochondrial bioenergetics at the onset of drug resistance in hematological malignancies: an overview. Front Oncol. 2020;10:604143.
Article PubMed PubMed Central Google Scholar
Jing F, et al. Unlocking the multifaceted molecular functions and diverse disease implications of lactylation. Biol Rev Camb Philos Soc. 2025;100(1):172–89.
Hu Y, et al. Lactylation: the novel histone modification influence on gene expression, protein function, and disease. Clin Epigenetics. 2024;16(1):72.
Article PubMed PubMed Central CAS Google Scholar
Zhu Z, et al. Potential of lactylation as a therapeutic target in cancer treatment (Review). Mol Med Rep. 2025. https://doi.org/10.3892/mmr.2025.13456.
Article PubMed PubMed Central Google Scholar
Li Q, et al. Lactylation in tumor immune escape and immunotherapy: multifaceted functions and therapeutic strategies. Research. 2025;8:p0793.
Li H, et al. Lactylation in cancer: current understanding and challenges. Cancer Cell. 2024;42(11):1803–7.
Article PubMed CAS Google Scholar
Yang Z, Zheng Y, Gao Q. Lysine lactylation in the regulation of tumor biology. Trends Endocrinol Metab. 2024;35(8):720–31.
Article PubMed CAS Google Scholar
Chen J, et al. Lactate and lactylation in cancer. Signal Transduct Target Ther. 2025;10(1):38.
Article PubMed PubMed Central CAS Google Scholar
Wang H, et al. PYCR1 promotes liver cancer cell growth and metastasis by regulating IRS1 expression through lactylation modification. Clin Transl Med. 2024;14(10):e70045.
Article PubMed PubMed Central CAS Google Scholar
Zhang C, et al. H3k18 lactylation potentiates immune escape of non-small cell lung cancer. Cancer Res. 2024;84(21):3589–601.
Article PubMed CAS Google Scholar
Deng J, et al. Histone lactylation enhances GCLC expression and thus promotes chemoresistance of colorectal cancer stem cells through inhibiting ferroptosis. Cell Death Dis. 2025;16(1):193.
Article PubMed PubMed Central CAS Google Scholar
Lu Y, et al. Lactylation-driven IGF2BP3-mediated serine metabolism reprogramming and RNA m6A-modification promotes lenvatinib resistance in HCC. Adv Sci. 2024;11(46):e2401399.
Shi P, Ma Y, Zhang S. Non-histone lactylation: unveiling its functional significance. Front Cell Dev Biol. 2025;13:1535611.
Article PubMed PubMed Central Google Scholar
Kong W, et al. Histone lactylation-related genes correlate with the molecular patterns and functions of cancer-associated fibroblasts and have significant clinical implications in clear cell renal cell carcinoma. Heliyon. 2024;10(13):e33554.
Article PubMed PubMed Central CAS Google Scholar
Gao M, et al. Machine learning-based prognostic model of lactylation-related genes for predicting prognosis and immune infiltration in patients with lung adenocarcinoma. Cancer Cell Int. 2024;24(1):400.
Comments (0)